This article was originally published in The Gray Sheet
Executive SummaryTerminates negotiations to acquire Advanced Spine Fixation Systems. The two companies signed a letter of intent in March under which Wright would have purchased all stock in Cypress, California-based Advanced Spine ("The Gray Sheet" March 7, In Brief). Wright officials cite an inability to specify terms as the cause of the breakdown in negotiations. Wright notes that it is "pursuing many other opportunities which will lead to our entry into this market"
You may also be interested in...
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.
FDA has little in the way of good information it can list on its CBD policy agenda so far, says Principal Deputy Commissioner Amy Abernethy. At recent regulatory conference, she said, "Like it or not, there is a massive human experiment going on right now. There’s CBD in most different product categories and people of many different backgrounds with potential vulnerabilities taking CBD."
FDA is worried about drug names that could appear to overstate efficacy and impact consumer and healthcare provider perceptions of the product.